MeVis Medical Solutions AG (XTER:M3V) ROCE % : 30.48% (As of Sep. 2023)

View and export this data going back to 2007. Start your Free Trial

What is MeVis Medical Solutions AG ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. MeVis Medical Solutions AG's annualized ROCE % for the quarter that ended in Sep. 2023 was 30.48%.

MeVis Medical Solutions AG ROCE % Historical Data

The historical data trend for MeVis Medical Solutions AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MeVis Medical Solutions AG ROCE % Chart

MeVis Medical Solutions AG Annual Data

Trend

Dec13

Dec14

Dec15

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

ROCE %

Get a 7-Day Free Trial

39.63

28.55

22.56

37.20

23.76

MeVis Medical Solutions AG Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
ROCE %	Get a 7-Day Free Trial															21.32	33.78	42.38	17.98	30.48

MeVis Medical Solutions AG ROCE % Calculation

MeVis Medical Solutions AG's annualized ROCE % for the fiscal year that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Sep. 2023 )		(A: Sep. 2022 )		(A: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Sep. 2023 )		(A: Sep. 2022 )		(A: Sep. 2023 )
	=	5.077	/	( ( (31.201 - 9.672)	+	(28.054 - 6.849) )	/ 2 )
	=	5.077	/	( (21.529	+	21.205)	/ 2 )
	=	5.077	/	21.367
	=	23.76 %

MeVis Medical Solutions AG's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2023 )		(Q: Mar. 2023 )		(Q: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2023 )		(Q: Mar. 2023 )		(Q: Sep. 2023 )
	=	6.366	/	( ( (24.374 - 3.801)	+	(28.054 - 6.849) )	/ 2 )
	=	6.366	/	( ( 20.573	+	21.205 )	/ 2 )
	=	6.366	/	20.889
	=	30.48 %

(1) Note: The EBIT data used here is two times the semi-annual (Sep. 2023) EBIT data.

MeVis Medical Solutions AG (XTER:M3V) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

MeVis Medical Solutions AG ROCE % Related Terms

Thank you for viewing the detailed overview of MeVis Medical Solutions AG's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

MeVis Medical Solutions AG (XTER:M3V) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MeVis Medical Solutions AG (XTER:M3V) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

M3V:Germany M3V:Germany

Address

Caroline-Herschel-Strasse 1, Bremen, DEU, 28359

Website

http://www.mevis.de

MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.

MeVis Medical Solutions AG (XTER:M3V) Headlines

No Headlines